Kevin Patrick Danahy - Sep 30, 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Executive Officer
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Sep 30, 2022
Transactions value $
$14,950
Form type
4
Date filed
10/3/2022, 04:35 PM
Previous filing
Sep 27, 2022
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $15K +6.5K $2.30 6.5K Sep 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase price represents the weighted average purchase price of the shares purchased on September 30, 2022, ranging from $2.28 to $2.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.